DH166, a beta-carboline derivative, inhibits the kinase activity of PLK1
Jing Zhang(Anhui University of Science and Technology), Shuyi Si(Chinese Academy of Medical Sciences & Peking Union Medical College), Jian‐Dong Jiang(Ningbo University), Yan Li(University of Science and Technology Beijing), Wei Jiang(Chinese Academy of Medical Sciences & Peking Union Medical College), Hong Yi(Central South University), Yanchang Wang(Florida State University), Rihui Cao(Sun Yat-sen University), Jialin Wu(The First Affiliated Hospital, Sun Yat-sen University), Liang Guo(Shanghai Medical College of Fudan University), Pei Zhao(Scripps Research Institute), Zhuorong Li(Chinese Academy of Medical Sciences & Peking Union Medical College), Qin Ma(The Ohio State University)
Cited by 59
Related Papers
ON01910, a non-ATP-competitive small molecule inhibitor of Plk1, is a potent anticancer agent
|Cancer Cell|2005|368
Berberine reduces insulin resistance through protein kinase C–dependent up-regulation of insulin receptor expression
|Metabolism|2008|265
LincRNA-Gm4419 knockdown ameliorates NF-κB/NLRP3 inflammasome-mediated inflammation in diabetic nephropathy
|Cell Death and Disease|2017|251
ROS-induced autophagy regulates porcine trophectoderm cell apoptosis, proliferation, and differentiation
|American Journal of Physiology-Cell Physiology|2018|204